Health and Fitness Health and Fitness
Fri, April 19, 2013
[ Fri, Apr 19th 2013 ] - Market Wire
Ceregene Reports Data From Parkinson's Disease Phase 2b Study
[ Fri, Apr 19th 2013 ] - Market Wire
Novo Nordisk Unveils New U.S. Headquarters
[ Fri, Apr 19th 2013 ] - Market Wire
CML HealthCare Inc.'s Subsidiary, Hemostasis Refe .. rded Contract Extension with Isis Pharmaceuticals
[ Fri, Apr 19th 2013 ] - Market Wire
Ceapro Reports Full-Year 2012 Financial and Operating Results
[ Fri, Apr 19th 2013 ] - Market Wire
BioScrip Prices Underwritten Offering of Common Stock
[ Fri, Apr 19th 2013 ] - Market Wire
iTech Medical, Inc. Enters Into Letter of Intent .. tal Ventures Inc. in Respect of a Proposed Merger
[ Fri, Apr 19th 2013 ] - Market Wire
Varian Medical Systems and Paul Scherrer Institut .. ounce Collaboration on Motion Management for IMPT
[ Fri, Apr 19th 2013 ] - Market Wire
Omeros to Present Additional OMS302 Clinical Data .. the Annual ASCRS and ASOA Symposium and Congress
[ Fri, Apr 19th 2013 ] - Market Wire
Interim PILLAR II Results Reported During SAGES
Thu, April 18, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
Harwood Feffer LLP Announces Investigation of AdCare Health, Inc.
[ Thu, Apr 18th 2013 ] - Market Wire
Masimo to Report First Quarter 2013 Financial Results after Market Close on Thursday, May 2
[ Thu, Apr 18th 2013 ] - Market Wire
Cempra, Inc. to Report First Quarter 2013 Financi .. Host Conference Call and Webcast on April 25, 20
[ Thu, Apr 18th 2013 ] - Market Wire
Sarepta Therapeutics to Present Company Overview at the Needham Annual Healthcare Conference
[ Thu, Apr 18th 2013 ] - Market Wire
Med BioGene Announces Adoption of Advance Notice Policy
[ Thu, Apr 18th 2013 ] - Market Wire
Johnson amp;; Johnson Announces Sale of Elan American Depositary Shares to Elan
[ Thu, Apr 18th 2013 ] - Market Wire
La Jolla Pharmaceutical Company Receives Orphan Designation From FDA for LJPC-6417
[ Thu, Apr 18th 2013 ] - Market Wire
Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
[ Thu, Apr 18th 2013 ] - Market Wire
Biologix Hair Inc. Establishes Medical Advisory B .. ;; Dr. Craig Ziering Appointed as Chairman
[ Thu, Apr 18th 2013 ] - Market Wire
RepliCel Receives Issue Notification from the Uni .. ark Office Protecting Methods of Preparing Dermal
[ Thu, Apr 18th 2013 ] - Market Wire
Life Technologies Partners with Ridom and Release .. + Software to Speed and Simplify Bacterial Typing
[ Thu, Apr 18th 2013 ] - Market Wire
NW Bio Announces That Another Brain Cancer Patien .. rials Has Surpassed Ten-Year Cancer-Free Survival
[ Thu, Apr 18th 2013 ] - Market Wire
NW Bio Announces $10 Million Registered Direct Offering
[ Thu, Apr 18th 2013 ] - Market Wire
Team USANA Partners Recognized By Utah Sports Com .. igious Honors at Governor's State of Sport Awards
[ Thu, Apr 18th 2013 ] - Market Wire
Insmed to Present at the 12th Annual Needham Healthcare Conference
[ Thu, Apr 18th 2013 ] - Market Wire
Unilife Develops Unifill Assurea" to Enhance Patient Self-Injection of Biologics
[ Thu, Apr 18th 2013 ] - Market Wire
UMeWorld New Trading Symbol "UMEWF" to Be Effective From April 18, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
Implant Sciences Showcases Its Explosive Trace De .. ection Equipment at Counter Terror Expo in London
[ Thu, Apr 18th 2013 ] - Market Wire
Accuray Provides Clarification on Recently Initiated Voluntary Recalls
[ Thu, Apr 18th 2013 ] - Market Wire
BD Anuncia Aprovao FDA 510(k) e Lanamento Comercial do BD UltraSafe PLUSa" Passive Needle Guard
[ Thu, Apr 18th 2013 ] - Market Wire
United Therapeutics Corporation To Announce First .. ts Before Market Open On Thursday, April 25, 2013

United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013


Published on 2013-04-18 04:00:44 - Market Wire
  Print publication without navigation


United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before... -- SILVER SPRING, Md., April 18, 2013 /PRNewswire/ --

SILVER SPRING, Md., April 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: [ UTHR ]) announced today that it will release its first quarter 2013 financial results before market open on Thursday, April 25, 2013.

United Therapeutics will host a half-hour teleconference on Thursday, April 25, 2013, at 9:00 a.m. Eastern Time.  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using conference code: 32040188.

This teleconference is also being webcast and can be accessed via United Therapeutics' website at [ http://ir.unither.com/events.cfm ].  [uthr-g]

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.

SOURCE United Therapeutics Corporation



RELATED LINKS
[ http://www.unither.com ]
Contributing Sources